XML 77 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:        
Net loss $ (7,020) $ (2,777) $ (6,763) $ (3,785)
Adjustments to reconcile net loss to net cash used in operating activities:        
Non-cash stock-based compensation expense 403 197 592 299
Intangible asset impairment 520 0    
Depreciation and amortization 583 393 866 795
Amortization of deferred loan fees     414 0
Gain on warrant liability, net of deferred loan fees amortization (388) 0 120 0
Gain on sale of property and equipment     (108) 0
Change in deferred rent 119 0 42 0
Deferred income taxes     58 7
Loss on write-off of software development costs     0 5
Changes in operating assets and liabilities, net of effects of acquisitions:        
Accounts receivable 665 (111) (1,528) 455
Prepaid expenses and other assets 265 (192) 42 (442)
Due to ancillary network (263) (145) 443 (1,235)
Accounts payable 163 (51) 403 (287)
Accrued liabilities 536 456 482 0
Net cash used in operating activities (4,575) (2,230) (4,034) (4,188)
Cash flows from investing activities:        
Net change in other non-current assets     (97) 0
Cost of acquisition 0 (2,180) (6,921) 0
Additions to property and equipment (138) (196) (776) (315)
Proceeds from sale of property and equipment     131 0
Net cash used in investing activities (138) (2,376) (7,663) (315)
Cash flows from financing activities:        
Proceeds from borrowings under line of credit 4,784 0 4,716 0
Principal payments on capital lease obligations (57) (1) (46) 0
Principal payments on long-term debt (554) (6)    
Offering costs, paid and deferred (22) 0 (124) 0
Proceeds from issuance of common stock 33 2,000 2,000 0
Notes payable payments     (36) 0
Proceeds from exercise of equity incentives     0 5
Net cash provided by financing activities 4,184 1,993 6,510 5
Net decrease in cash and cash equivalents (529) (2,613) (5,187) (4,498)
Cash and cash equivalents at beginning of period 1,020 6,207 6,207 10,705
Cash and cash equivalents at end of period 491 3,594 1,020 6,207
Supplemental cash flow information:        
Cash paid for taxes, net of refunds 0 25 38 117
Cash paid for interest 117 0 84 0
Supplemental non-cash operating and financing activity:        
Offering costs, unpaid and deferred 7 0    
Reclassified property and equipment from prepaid expenses 51 0    
Warrants issued as loan guarantee and financing     3,080 0
Fair value of debt issued as consideration in acquisitions     1,297 0
Purchase price due to seller, Stat Medical     268 0
Offering costs, deferred and unpaid     101 0
Receivable for tenant improvement allowance     180 0
Debt issued for property and equipment     40 0
Healthsmart [Member]        
Changes in operating assets and liabilities, net of effects of acquisitions:        
Due to ancillary network $ (158) $ 0 $ 903 $ 0